Recent cybersecurity report by Armis highlights the impact of geopolitical issues on cybersecurity, leading to an increase in cyberattacks.

Novo Nordisk Gets New Complement System Approach to Rare Diseases With Deal for Omeros Drug
Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused